Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$5.06 - $10.78 $26,205 - $55,829
-5,179 Closed
0 $0
Q1 2021

May 07, 2021

BUY
$5.64 - $23.33 $26,953 - $111,494
4,779 Added 1194.75%
5,179 $36,000
Q2 2020

Aug 13, 2020

BUY
$1.68 - $8.85 $504 - $2,655
300 Added 300.0%
400 $4,000
Q1 2020

May 12, 2020

BUY
$0.34 - $2.87 $34 - $287
100 New
100 $0

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $91.1M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.